Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LLY crawled date : 2021 - 11 - 02 save search
Lilly to Supply 614,000 Additional Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab to the U.S. Government for the Treatment or Post-Exposure Prevention of COVID-19
Published: 2021-11-02 (Crawled : 23:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K
|
|
| O: -0.41%
H: 5.54%
C: 4.54%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
covid treatment
Merus Announces Regulatory Update on Zenocutuzumab, Financial Results for the Third Quarter and Provides Business Update
Published: 2021-11-02 (Crawled : 21:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: 0.0%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 1.64%
H: 6.45%
C: 2.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
financial results results
Lilly to supply 614,000 additional doses of bamlanivimab and etesevimab to the U.S. Government for the treatment or post-exposure prevention of COVID-19
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.26%
H: 2.0%
C: 1.15%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
covid treatment
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.14%
H: 0.94%
C: -1.98%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.58%
H: 0.42%
C: 0.24%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 3.46%
H: 0.7%
C: -0.09%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 2.06%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.16%
H: 0.75%
C: -0.19%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.13%
H: 3.09%
C: 2.62%
ARVN | $34.78 1.43% 1.41% 940K
|
Health Technology
|
| O: 1.4%
H: 4.09%
C: 4.07%
results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.